|
|
|
40
|
B051B
|
DOLUTEGRAVIR 50MG TAB (APL/ATB)
|
DOLUTEGRAVIR
|
DOLUTEGRAVIR
|
30'S
|
BL
|
10.66
|
0.36
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08180812
|
INTEGRASE INHIBITORS
|
2022-04-12
|
2024-03-31
|
Add to Contract as Cat B
|
oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-04-12
|
|
|
|
41
|
B051D
|
DOLUTEGRAVIR 50MG TAB (MCP) (BL)
|
DOLUTEGRAVIR
|
DOLUTEGRAVIR
|
30'S
|
BL
|
9.27
|
0.309
|
TAB
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180812
|
INTEGRASE INHIBITORS
|
2024-04-01
|
2024-12-27
|
|
ORAL
|
0
|
INTEGRASE INHIBITORS
|
|
|
|
|
41
|
B051D
|
DOLUTEGRAVIR 50MG TAB (MCP) (BL)
|
DOLUTEGRAVIR
|
DOLUTEGRAVIR
|
30'S
|
BL
|
10.53
|
0.351
|
TAB
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180812
|
INTEGRASE INHIBITORS
|
2024-12-28
|
2026-03-31
|
|
ORAL
|
0
|
INTEGRASE INHIBITORS
|
2024-12-27
|
|
|
|
40
|
B0611
|
VALDOXAN 25MG TAB (SER/STO) AGOMELATINE
|
AGOMELATINE
|
VALDOXAN
|
28'S
|
BP
|
65.24
|
2.33
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B0611
|
VALDOXAN 25MG TAB (SER) AGOMELATINE (BP)
|
AGOMELATINE
|
VALDOXAN
|
28'S
|
BP
|
65.43
|
2.3368
|
TAB
|
84
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIDEPRESSANTS MISCELLANEOUS
|
|
|
|
|
40
|
B0612
|
VALDOXAN 25MG TAB (SER/COL) AGOMELATINE
|
AGOMELATINE
|
VALDOXAN
|
28'S
|
BP
|
65.24
|
2.33
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B0612
|
VALDOXAN 25MG TAB (SER) AGOMELATINE (BP)
|
AGOMELATINE
|
VALDOXAN
|
28'S
|
BP
|
65.43
|
2.3368
|
TAB
|
84
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIDEPRESSANTS MISCELLANEOUS
|
|
|
|
|
40
|
B0718
|
KEPPRA 500MG TAB (GSK/COL) LEVETIRACETAM
|
LEVETIRACETAM
|
KEPPRA
|
30'S
|
C
|
76.33
|
2.54
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B0718
|
KEPPRA 500MG TAB (GSK) LEVETIRACETA (B)
|
LEVETIRACETAM
|
KEPPRA
|
30'S
|
B
|
83.97
|
2.799
|
TAB
|
120
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
B071A
|
KEPPRA 1G TAB (GSK/COL) LEVETIRACETAM
|
LEVETIRACETAM
|
KEPPRA
|
30'S
|
C
|
97.04
|
3.23
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B071A
|
KEPPRA 1G TAB (GSK) LEVETIRACETAM (B)
|
LEVETIRACETAM
|
KEPPRA
|
30'S
|
B
|
106.75
|
3.5583
|
TAB
|
60
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
B071D
|
QUETRA 500MG TAB (REM) LEVETIRACETA
|
LEVETIRACETAM
|
QUETRA
|
30'S
|
BQ
|
11.77
|
0.3923
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-02
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-02
|
|
|
|
40
|
B071F
|
LEVETIRACETAM 500MG TAB (REM/SBI)
|
LEVETIRACETAM
|
LEVETIRACETAM
|
100'S
|
B
|
23.46
|
0.23
|
TABLET
|
0
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B071F
|
LEVETIRACETAM 500MG TAB (REM) (B)
|
LEVETIRACETAM
|
LEVETIRACETAM
|
100'S
|
B
|
39.12
|
0.3912
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2024-05-14
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-02
|
|
|
|
40
|
B071G
|
KOPODEX 1G TAB (ABB/PHA) LEVETIRACETAM
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
B
|
68.88
|
2.30
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
B071G
|
KOPODEX 1G TAB (ABB/PHA) LEVETIRACETAM(B)
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
B
|
68.88
|
2.296
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|
|
|
|
40
|
B071H
|
KOPODEX 500MG TAB (ABB/PHA) LEVETIRACETAM
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
C
|
58.55
|
1.95
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
B071H
|
KOPODEX 500MG TAB (ABB/PHA) LEVETIRACETAM (C)
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
C
|
58.55
|
1.9517
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|
|
|
|
40
|
B071HHH
|
KOPODEX 500MG TAB (ABB/PHA) LEVETIRACETAM (C)
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
C
|
58.55
|
1.9517
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|
|
|
|
40
|
B071HHH
|
KOPODEX 500MG TAB (ABB/PHA) LEVETIRACETAM (C)
|
LEVETIRACETAM
|
KOPODEX
|
30'S
|
C
|
58.55
|
1.9517
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
2023-03-02
|